Quantification of adipose tissue insulin sensitivity

Journal of Investigative Medicine

Volumn 64, Issue 5, 2016, Pages 989-991

  Søndergaard, Esben ^a,b,c   Jensen, Michael D ^a  

^a MAYO CLINIC   (United States)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

^c The Danish Diabetes Academy   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID; INSULIN; TRIACYLGLYCEROL;

ADIPOSE TISSUE; FATTY ACID BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN RESPONSE; INSULIN SENSITIVITY; LIPOLYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; REVIEW; BIOLOGICAL MODEL; METABOLISM;

ADIPOSE TISSUE; HUMANS; INSULIN; INSULIN RESISTANCE; LIPOLYSIS; MODELS, BIOLOGICAL;

EID: 84980037565     PISSN: 17088267     EISSN: None     Source Type: Journal    
DOI: 10.1136/jim-2016-000098     Document Type: Review

References (17)

1. Groop LC, Bonadonna RC, DelPrato S, et al. Glucose and free fatty acid metabolism in non-insulin-dependent diabetes mellitus. evidence for multiple sites of insulin resistance. J Clin Invest 1989;84:205-13.
2. Ferrannini E, Barrett EJ, Bevilacqua S, et al. Effect of fatty acids on glucose production and utilization in man. J Clin Invest 1983;72:1737-47.
3. Nielsen S, Guo Z, Albu JB, et al. Energy expenditure, sex, and endogenous fuel availability in humans. J Clin Invest 2003;111:981-8.
4. Miles JM, Ellman MG, McClean KL, et al. Validation of a new method for determination of free fatty acid turnover. Am J Physiol 1987;252:E431-8.
5. Mittendorfer B, Liem O, Patterson BW, et al. What does the measurement of whole-body fatty acid rate of appearance in plasma by using a fatty acid tracer really mean? Diabetes 2003;52:1641-8.
6. Jensen MD, Chandramouli V, Schumann WC, et al. Sources of blood glycerol during fasting. Am J Physiol Endocrinol Metab 2001;281: E998-E1004.
7. Groop LC, Saloranta C, Shank M, et al. The role of free fatty acid metabolism in the pathogenesis of insulin resistance in obesity and noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1991;72:96-107.
8. Jensen MD, Caruso M, Heiling V, et al. Insulin regulation of lipolysis in nondiabetic and IDDM subjects. Diabetes 1989;38:1595-601.
9. Jensen MD, Nielsen S. Insulin dose response analysis of free fatty acid kinetics. Metab Clin Exp 2007;56:68-76.
10. Bergman RN, Ider YZ, Bowden CR, et al. Quantitative estimation of insulin sensitivity. Am J Physiol 1979;236:E667-77.
11. Periwal V, Chow CC, Bergman RN, et al. Evaluation of quantitative models of the effect of insulin on lipolysis and glucose disposal. Am J Physiol Regul Integr Comp Physiol 2008;295:R1089-96.
12. Boston RC, Moate PJ. NEFA minimal model parameters estimated from the oral glucose tolerance test and the meal tolerance test. Am J Physiol Regul Integr Comp Physiol 2008;295:R395-403.
13. Thomaseth K, Brehm A, Pavan A, et al. Modeling glucose and free fatty acid kinetics during insulin-modified intravenous glucose tolerance test in healthy humans: role of counterregulatory response. Am J Physiol Regul Integr Comp Physiol 2014;307:R321-31.
14. Kashyap S, Belfort R, Gastaldelli A, et al. Asustained increase in plasma free fatty acids impairs insulin secretion in nondiabetic subjects genetically predisposed to develop type 2 diabetes. Diabetes 2003;52:2461-74.
15. Gastaldelli A, Harrison SA, Belfort-Aguilar R, et al. Importance of changes in adipose tissue insulin resistance to histological response during thiazolidinedione treatment of patients with nonalcoholic steatohepatitis. Hepatology 2009;50:1087-93.
16. Abdul-Ghani MA, Molina-Carrion M, Jani R, et al. Adipocytes in subjects with impaired fasting glucose and impaired glucose tolerance are resistant to the anti-lipolytic effect of insulin. Acta Diabetol 2008;45:147-50.
17. Fabbrini E, Magkos F, Conte C, et al. Validation of a novel index to assess insulin resistance of adipose tissue lipolytic activity in obese subjects. J Lipid Res 2012;53:321-4.